Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).

7 Aug 2012

High maternal choline intake may reduce risk of hypertension and diabetes in babies

New research from Cornell University indicates that pregnant women who increase choline intake in the third trimester of pregnancy may reduce the risk of the baby developing metabolic and chronic stress-related diseases like high blood pressure and diabetes later in life.

2 Aug 2012

KSU researcher completes study that examines dietary fiber in children

Experts have long since determined the recommended daily amounts of certain nutrients, such as calcium and vitamin D, but the numbers for nutrients like fiber have proven more difficult to nail down.

31 Jul 2012

Elan second quarter total revenue increases 6% to $288.0 million

Elan Corporation, plc today reported its second quarter and first half 2012 financial results.

25 Jul 2012

Topline results from first of four Phase 3 studies of Pfizer's bapineuzumab for Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who carry the ApoE4 (apolipoprotein E epsilon 4) genotype.

24 Jul 2012

Top-line result from Pfizer Bapineuzumab Phase 3 studies on Alzheimer's

Elan Corporation, plc announced today that Pfizer has issued a top-line result in the first of four Bapineuzumab Phase 3 studies carried out by Pfizer and Janssen AI.

24 Jul 2012

Riverain's ClearRead Bone Suppression software improves detection of lung cancer

Software by Riverain Technologies significantly improves radiologists' ability to detect potentially cancerous lung nodules in X-ray images, and might be a cost-effective alternative to dual energy subtraction (DES) imaging, according to two new studies being presented at the 20th Anniversary Meeting of the European Society of Thoracic Imaging (ESTI), June 22-24, in London.

23 Jun 2012

Distinct brain regions organize objects based on their physical size

The human brain can recognize thousands of different objects, but neuroscientists have long grappled with how the brain organizes object representation; in other words, how the brain perceives and identifies different objects. Now researchers at the MIT Computer Science and Artificial Intelligence Lab (CSAIL) and the MIT Department of Brain and Cognitive Sciences have discovered that the brain organizes objects based on their physical size, with a specific region of the brain reserved for recognizing large objects and another reserved for small objects.

21 Jun 2012

Artificial noses could allow quick disease screening and ultimately transform diagnostics

Artificial noses have, until now, been used to detect diseases such as urinary tract infection, Helicobacter pylori, tuberculosis, ear, nose and throat conditions and even lung cancer. They have also been clinically tested for use in continuous monitoring of different disease stages.

7 Jun 2012

Distinctive protein pathways in certain leukemia patients

Scientists at Rice University and the University of Texas MD Anderson Cancer Center have successfully profiled protein pathways found to be distinctive to leukemia patients with particular variants of the disease.

1 Jun 2012

Researchers develop tentative model for diagnosis of colon cancer

Researchers from the Universidad Politécnica de Madrid's Facultad de Informática, the Universidad del País Vasco, the Gaiker Technology Centre (Biscay) and the Hospital de Cruces in Barakaldo, have developed a tentative model for the diagnosis of colon cancer based on a biomarker panel.

28 May 2012

Optimi prototype effectively predicts people at risk of depression

The computing tool, developed by researchers at the Universitat Jaume I in Castellón, the Universitat Politècnica of València and the Universitat de València, along with professionals from the company everis, is able to predict if a person with a high-stress level is at risk of becoming depressed, based on the study of a series of physiological and psychological variables in which artificial intelligence techniques are used.

24 May 2012

Science journal’s NEWSFOCUS section describes recent advances in sequencing technology

Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.

From Oxford Nanopore Technologies 23 May 2012

Portfolio theory applied to basic science research portfolio

Researchers suggest that application of Nobel-prize-winning portfolio theory could provide objective funding allocations that would improve risk/reward trade-off in years of life lost.

3 May 2012

Elan first quarter total revenue increases 17% to $288.4 million

Elan Corporation, plc, today reported its first quarter 2012 financial results.

26 Apr 2012

Online tool can accurately diagnose autism within minutes

Researchers at Harvard Medical School have significantly reduced from hours to minutes the time it takes to accurately detect autism in young children.

12 Apr 2012

Paul Allen pledges $300 million to better understand the brain’s inner workings

Microsoft co-founder and billionaire Paul Allen is donating $300 million to his Allen Institute for Brain Science to fund new projects to map and observe the human brain and, in Allen’s words, “to one day understand the essence of what makes us human.” That brings the total amount Allen has invested in the Institute to half a billion.

25 Mar 2012

Ultrasound system to track patients in hospitals

Patients admitted to hospitals in the future may find themselves equipped with a small ultrasound transmitter. With the help of their mobile phones, health care personnel will be able to keep track of where their patients are as well as any delays in their scheduled treatment.

14 Mar 2012

Special computer algorithms can help doctors to make rapid diagnoses of known diseases

Just like urine and blood, breath contains traces of the products of metabolism. Such products can also be signs of infection, inflammation or cancer. For their analysis, computational bioinformatics researchers at the Cluster of Excellence "Multimodal Computing and Interaction" at Saarland University developed special computer algorithms that can help doctors to make diagnoses quickly and reliably.

5 Mar 2012

UMMS' iHeal project uses emerging technologies to detect drug cravings and intervene

Clinical researchers at the University of Massachusetts Medical School (UMMS) are combining an innovative constellation of technologies such as artificial intelligence, smartphone programming, biosensors and wireless connectivity to develop a device designed to detect physiological stressors associated with drug cravings and respond with user-tailored behavioral interventions that prevent substance use.

22 Feb 2012

Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

High maternal choline intake may reduce risk of hypertension and diabetes in babies

KSU researcher completes study that examines dietary fiber in children

Elan second quarter total revenue increases 6% to $288.0 million

Topline results from first of four Phase 3 studies of Pfizer's bapineuzumab for Alzheimer's

Top-line result from Pfizer Bapineuzumab Phase 3 studies on Alzheimer's

Riverain's ClearRead Bone Suppression software improves detection of lung cancer

Distinct brain regions organize objects based on their physical size

Artificial noses could allow quick disease screening and ultimately transform diagnostics

Distinctive protein pathways in certain leukemia patients

Researchers develop tentative model for diagnosis of colon cancer

Optimi prototype effectively predicts people at risk of depression

Science journal’s NEWSFOCUS section describes recent advances in sequencing technology

Portfolio theory applied to basic science research portfolio

Elan first quarter total revenue increases 17% to $288.4 million

Online tool can accurately diagnose autism within minutes

Paul Allen pledges $300 million to better understand the brain’s inner workings

Ultrasound system to track patients in hospitals

Special computer algorithms can help doctors to make rapid diagnoses of known diseases

UMMS' iHeal project uses emerging technologies to detect drug cravings and intervene

AI In Healthcare eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

AI In Healthcare eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in